Kidney-Sparing Surgery Offers Effective Oncologic Control in High-Risk UTUC
In this small study, even patients with high-risk tumors appeared to benefit from nephron-sparing surgery.
In this small study, even patients with high-risk tumors appeared to benefit from nephron-sparing surgery.
If validated, the EpiCheck® assay may identify more patients who can safely delay or avoid nephroureterectomy.
Older age independently predicted significant 48% lower odds of the gold standard treatment of NAC and radical cystectomy.
Study results support an attempt at bladder preservation in patients with BCG-unresponsive nonmuscle-invasive bladder cancer.
At prostate cancer diagnosis, clinical T stage was significantly higher among 5-ARI users compared with nonusers.
In a small study, most BCG-unresponsive patients who were initially managed conservatively ultimately underwent cystectomy.
Investigators question initiation of continuous androgen deprivation therapy (ADT) for biochemically recurrent prostate cancer without metastasis.
An appropriate vaccination strategy will follow.
Decisions of how to proceed when positive surgical margins are found after partial nephrectomy are left to the discretion of the surgeon.
In a trial of men who volunteered for PSA screening, detection of clinically insignificant tumors and benign findings were reduced when prostate biopsy was performed only in those with positive MRI results.